TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT00842621 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT00842621 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Lactate dehydrogenase
Study NCT03479983 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT01013441 — Predictive Biomarker (PRD): CD28 mRNA
Genes: CD28
Study NCT01013441 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT03485859 — Predictive Biomarker (PRD): ERAS mRNA
Genes: ERAS; HRAS2; HRASP
Study NCT02067026 — Predictive Biomarker (PRD): CD14 mRNA
Genes: CD14
Study NCT02067026 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02067026 — Surrogate Endpoint (SUR): Serum LDL cholesterol
Study NCT03507595 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT00005610 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT03313934 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT02975960 — Predictive Biomarker (PRD): PDE5A mRNA
Genes: PDE5A; PDE5
Study NCT01668004 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT02889341 — Surrogate Endpoint (SUR): Sperm parameters
Study NCT03568799 — Predictive Biomarker (PRD): SLC1A5 mRNA
Genes: SLC1A5; ASCT2; M7V1; RDR; RDRC
Study NCT04233021 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT04233021 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT02487511 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HP mRNA
Genes: HP
Study NCT02007629 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03121521 — Predictive Biomarker (PRD): GGT1 mRNA
Genes: GGT1; GGT
Study NCT03085680 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT02261961 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT02261961 — Safety Biomarker (SAF): Interleukin 1
Study NCT03425630 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT03425630 — Surrogate Endpoint (SUR): Serum triglycerides
Study NCT03425630 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04084041 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT03528902 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT01276574 — Monitoring Biomarker (MOI): Ovarian carcinoma antigen CA125
Genes: MUC16; CA125
Study NCT02028637 — Predictive Biomarker (PRD): TLR4 mRNA
Genes: TLR4
Study NCT03784248 — Predictive Biomarker (PRD): NLRP3 mRNA
Genes: NLRP3; C1orf7; CIAS1; NALP3; PYPAF1
Study NCT01065636 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT02590107 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study NCT00897026 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00872300 — Predictive Biomarker (PRD): FGFR3 mRNA
Genes: FGFR3; JTK4
Study NCT00242853 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT00242853 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study NCT04399525 — Pharmacodynamic Biomarker (PDY): Dermal blood flow
Study NCT04555265 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04555265 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study NCT04555265 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): C-X-C motif chemokine 9
Genes: CXCL9; CMK; MIG; SCYB9
Study NCT04555265 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-X-C motif chemokine 10
Genes: CXCL10; INP10; SCYB10
Study NCT04555265 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-C motif chemokine 2
Genes: CCL2; MCP1; SCYA2
Study NCT04555265 — Safety Biomarker (SAF): T-cell specific protein RANTES
Genes: CCL5; D17S136E; SCYA5
Study NCT02588885 — Predictive Biomarker (PRD): PTS mRNA
Genes: PTS
Study NCT00740181 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT01378117 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT00078533 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT00424762 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT01656161 — Surrogate Endpoint (SUR): Serum testosterone
Study NCT04118205 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00281593 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01494662 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT01769924 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01287494 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT03695107 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT02296268 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00499837 — Predictive Biomarker (PRD): SERPINA1 mRNA
Genes: SERPINA1; AAT; PI; PRO0684; PRO2209
Study NCT03436342 — Predictive Biomarker (PRD): CXCR4 mRNA
Genes: CXCR4
Study NCT01150357 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00594789 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT00596167 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03683628 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT01455051 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study NCT03275077 — Pharmacodynamic Biomarker (PDY): Blood coagulation
Study NCT00320502 — Predictive Biomarker (PRD): MB mRNA
Genes: MB
Study NCT00544440 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CYP17A1 mRNA
Genes: CYP17A1; CYP17; S17AH
Study NCT01740817 — Predictive Biomarker (PRD): TLR4 mRNA
Genes: TLR4
Study NCT00444613 — Predictive Biomarker (PRD): IGFALS mRNA
Genes: IGFALS; ALS
Study NCT02948439 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03098095 — Predictive Biomarker (PRD): F12 mRNA
Genes: F12
Study NCT03098095 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study NCT00557037 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study NCT02348190 — Predictive Biomarker (PRD): PI3 mRNA
Genes: PI3; WAP3; WFDC14
Study NCT02348190 — Pharmacodynamic Biomarker (PDY): Insulin receptor substrate 1
Genes: IRS1
Study NCT02348190 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study NCT04585750 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study NCT04875130 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Adrenomedullin
Genes: ADM; AM
Study NCT02148133 — Surrogate Endpoint (SUR): Hematologic response
Study NCT04232852 — Predictive Biomarker (PRD): NLRP3 mRNA
Genes: NLRP3; C1orf7; CIAS1; NALP3; PYPAF1
Study NCT04232852 — Predictive Biomarker (PRD): CASP1 mRNA
Genes: CASP1; IL1BC; IL1BCE
Study NCT00099255 — Predictive Biomarker (PRD): Lymphocyte activation antigen CD30
Genes: TNFRSF8; CD30; D1S166E
Study NCT00810225 — Predictive Biomarker (PRD): CNDP1 mRNA
Genes: CNDP1; CN1; CPGL2; UNQ1915/PRO4380
Study NCT01430390 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT01597154 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01597154 — Surrogate Endpoint (SUR): Serum LDL cholesterol
Study NCT01597154 — Surrogate Endpoint (SUR): Serum triglycerides
Study NCT04518501 — Predictive Biomarker (PRD): Homologous recombination deficiency
Study NCT03312335 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 2 receptor alpha
Genes: IL2RA
Study NCT03312335 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT03399448 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HLA-A
Study NCT00140140 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT00140140 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT01784029 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03743246 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT00822302 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study NCT02961127 — Predictive Biomarker (PRD): TFPI mRNA
Genes: TFPI; LACI; TFPI1
Study NCT02016716 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT01843530 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT00092833 — Predictive Biomarker (PRD): FH mRNA
Genes: FH
Study NCT01182285 — Pharmacodynamic Biomarker (PDY): Valproic acid
Study NCT01182285 — Safety Biomarker (SAF): Thyroid stimulating hormone
Study NCT04943237 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05003193 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04473586 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study NCT03671525 — Predictive Biomarker (PRD): CACNA1C mRNA
Genes: CACNA1C; CACH2; CACN2; CACNL1A1; CCHL1A1
Study NCT04126330 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT00541125 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT04246619 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study NCT00541606 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05918159 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT03200002 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT02286895 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT01561911 — Predictive Biomarker (PRD): CD40 mRNA
Genes: CD40; TNFRSF5
Study NCT00440973 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT00817635 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04457024 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT03862833 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT00456274 — Predictive Biomarker (PRD): IHH mRNA
Genes: IHH
Study NCT00516282 — Predictive Biomarker (PRD): O-6-methylguanine-DNA-alkyltransferase
Genes: MGMT
Study NCT02106442 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT02096042 — Predictive Biomarker (PRD): Lymphocyte activation antigen CD30
Genes: TNFRSF8; CD30; D1S166E
Study NCT01885988 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00512564 — Predictive Biomarker (PRD): Liver iron
Study NCT01816295 — Surrogate Endpoint (SUR): Serum testosterone
Study NCT04637152 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00736632 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03375255 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study NCT04303858 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT04153487 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04153487 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT04153487 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study NCT04153487 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 10
Genes: IL10
Study NCT04153487 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study NCT01659060 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02272127 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02272127 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT01420965 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT00114491 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT04052061 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT02551315 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT01464879 — Surrogate Endpoint (SUR): Serum testosterone
Study NCT00617864 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT04588480 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT03495284 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00147329 — Predictive Biomarker (PRD): AFP mRNA
Genes: AFP; HPAFP
Study NCT00967616 — Predictive Biomarker (PRD): CS mRNA
Genes: CS
Study NCT03970590 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02886793 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT00853827 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01258673 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04237896 — Predictive Biomarker (PRD): FEV mRNA
Genes: FEV; PET1
Study NCT01374425 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT01374425 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT01374425 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT00626457 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02573792 — Predictive Biomarker (PRD): AQP4 mRNA
Genes: AQP4
Study NCT02205320 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT02441894 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT02361892 — Predictive Biomarker (PRD): AMH mRNA
Genes: AMH; MIF
Study NCT02321228 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study NCT02894398 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT02894398 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05231863 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04652817 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT02083224 — Predictive Biomarker (PRD): DNA mismatch repair protein MSH2
Genes: MSH2
Study NCT01219699 — Predictive Biomarker (PRD): PIK3CA mRNA
Genes: PIK3CA
Study NCT03977116 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT00509769 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04271800 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT04319757 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04174352 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT03838744 — Predictive Biomarker (PRD): STS mRNA
Genes: STS; ARSC1
Study NCT03720366 — Predictive Biomarker (PRD): IDH2 mRNA
Genes: IDH2
Study NCT00558818 — Monitoring Biomarker (MOI): HBV DNA
Study NCT02499419 — Predictive Biomarker (PRD): MVP mRNA
Genes: MVP; LRP
Study NCT02031614 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT00431431 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT04654221 — Safety Biomarker (SAF): Cystatin C
Genes: CST3
Study NCT04654221 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT00078221 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT03528317 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HP mRNA
Genes: HP
Study NCT02772029 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT02772029 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT02862574 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03759496 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT00565565 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00565565 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study NCT03823989 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT03823989 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT03299816 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01953757 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study NCT00968409 — Predictive Biomarker (PRD): Hormone receptor
Study NCT04038073 — Predictive Biomarker (PRD): IRAK1 mRNA
Genes: IRAK1; IRAK
Study NCT01414842 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00904371 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02668666 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT02668666 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02668666 — Predictive Biomarker (PRD): Hormone receptor
Study NCT06338111 — Monitoring Biomarker (MOI): Procalcitonin
Study NCT06338111 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT06338111 — Predictive Biomarker (PRD): AZU1 mRNA
Genes: AZU1
Study NCT06338111 — Monitoring Biomarker (MOI): Urokinase plasminogen activator surface receptor
Genes: PLAUR; MO3; UPAR
Study NCT06338111 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT02981628 — Predictive Biomarker (PRD): CD22 mRNA
Genes: CD22; SIGLEC2
Study NCT02300233 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT04670809 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01752465 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00319397 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03833921 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study NCT03325504 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT04483778 — Predictive Biomarker (PRD): CD276 mRNA
Genes: CD276; B7H3; PSEC0249; UNQ309/PRO352
Study NCT04483778 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT03831620 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT01425476 — Predictive Biomarker (PRD): PGD mRNA
Genes: PGD; PGDH
Study NCT03869112 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study NCT03869112 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT02786407 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02563782 — Predictive Biomarker (PRD): RPE mRNA
Genes: RPE; HUSSY-17
Study NCT02563782 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT03310996 — Predictive Biomarker (PRD): NF1 mRNA
Genes: NF1
Study NCT01677104 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT02740465 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT05600413 — Predictive Biomarker (PRD): CIT mRNA
Genes: CIT; CRIK; KIAA0949; STK21
Study NCT03789708 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT02268630 — Predictive Biomarker (PRD): PTS mRNA
Genes: PTS
Study NCT06359054 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT06359054 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT06359054 — Predictive Biomarker (PRD): Hormone receptor
Study NCT00305695 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT03433950 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01572974 — Predictive Biomarker (PRD): HGD mRNA
Genes: HGD; HGO
Study NCT00303836 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT00303836 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT00476060 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT00794118 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT01023828 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT02686554 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT03200470 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT03200470 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study NCT02674750 — Predictive Biomarker (PRD): MYC mRNA
Genes: MYC; BHLHE39
Study NCT04514419 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT01251354 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT04487236 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02632747 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT00730925 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT00730925 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00681252 — Predictive Biomarker (PRD): FLT1 mRNA
Genes: FLT1; FLT; FRT; VEGFR1
Study NCT00681252 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor receptor 2
Genes: KDR; FLK1; VEGFR2
Study NCT00681252 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HLA-A
Study NCT02299336 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT02235857 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT04288089 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT01676090 — Predictive Biomarker (PRD): IGFALS mRNA
Genes: IGFALS; ALS
Study NCT02651480 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04681768 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT04681768 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study NCT04681768 — Predictive Biomarker (PRD): Hormone receptor
Study NCT03911297 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01499108 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02314442 — Predictive Biomarker (PRD): PCSK9 mRNA
Genes: PCSK9; NARC1; PSEC0052
Study NCT02314442 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT02669524 — Pharmacodynamic Biomarker (PDY): Gastric inhibitory polypeptide
Genes: GIP
Study NCT02899286 — Safety Biomarker (SAF): Arginase-1
Genes: ARG1
Study NCT04119713 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT02857491 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT03646123 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT03646123 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT00904956 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study NCT00953706 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study NCT00953706 — Predictive Biomarker (PRD): CFTR
Genes: MRP7; ABC35; TNR-CFTR; dJ760C5.1; CFTR/MRP